Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
111C-flumazenil
(Romazicon)		[1] Flumazenil (Romazicon)[1] Flumazenil (Romazicon) 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 206 💬
211C]flumazenil
(Romazicon)		[1] Flumazenil (Romazicon)[1] Flumazenil (Romazicon) 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13 💬
31500mg mesalazine pellets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
418F-RO6958948----[3] 5, 7, 127 💬
5250mg mesalazine pellets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
6500mg mesalazine pellets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
7750mg mesalazine pellets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
8[18F]flumazenil
(Romazicon)		[1] Flumazenil (Romazicon)[1] Flumazenil (Romazicon) 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 206 💬
9ACT-050089 (Ro 61-0612)----[1] 86 💬
10Azathioprine OR Mesalazine
(Rowasa)		[2] Azathioprine,
Mesalazine (Rowasa)		[2] Azathioprine ,
Mesalamine (Rowasa) 💬 		--[1] 96 💬
11Benznidazole
(Rochagan)		[1] Benznidazole[1] Benznidazole (Rochagan) 💬 --[1] 65 💬
12BMS-986089-01 (RO7239361) , anti-myostatin----[1] 113 💬
13BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL)----[1] 113 💬
14BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL)----[1] 113 💬
15BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL)----[1] 113 💬
16BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL)----[1] 113 💬
17BMS-986089-01 (RO7239361), anti-myostatin----[1] 113 💬
18Butyrate enemas + routine management[1] Butyric Acid---[1] 291 💬
19C5 inh MAb, SKY59, RO/CH7092230----[2] 62, 109 💬
20Calcitriol
(Rocaltrol)		[1] Calcitriol (Rocaltrol)[1] Calcitriol (Rocaltrol) 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[9] 18, 37, 46, 49, 66, 96, 158, 235, 326 💬
21Calcitriol & Calcium
(Rocaltrol)		[2] Calcitriol (Rocaltrol),
Calcium (Rocky Mountain Multiple Vit and Min Mega Tab)		[1] Calcitriol (Rocaltrol) 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 235 💬
22Calcium rosuvastatin[2] Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin (Ag-rosuvastatin)		[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 79 💬
23Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[2] 96, 97 💬
24Crestor Tablets (calcium rosuvastatin) Film-Coated tablets[2] Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin (Ag-rosuvastatin)		[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 79 💬
25Delayed and extended release mesalazine
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
26Delayed Release 6MP or Calcitriol vs. Purinethol
(Rocaltrol)		[1] Calcitriol (Rocaltrol)[1] Calcitriol (Rocaltrol) 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 96 💬
27Dexmedetomidine with ropivacaine[2] Dexmedetomidine,
Ropivacaine (Ropivacaine Hydrochloride Injection USP)		[2] Dexmedetomidine ,
Ropivacaine (Ropivacaine) 💬 		[8] ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬[1] 70 💬
28Dopamine Agonists (pramipexole, ropirinole)[2] Dopamine,
Pramipexole		[2] Pramipexole ,
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
29Emicizumab (ACE910, RO5534262)[1] Emicizumab[1] Emicizumab 💬 [2] F10,
F9 💬 		[1] Complement and coagulation cascades 💬[1] 288 💬
30EU-approved RoActemra[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
31Flumazenil
(Romazicon)		[1] Flumazenil (Romazicon)[1] Flumazenil (Romazicon) 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[5] 6, 13, 17, 18, 206 💬
32Gamma-secretase/Notch signalling pathway inhibitor RO4929097----[1] 74 💬
33GDC-0853 RO7010939----[3] 13, 46, 49 💬
34GLYCYRRHIZA GLABRA ROOT[1] Glycyrrhiza glabra (Glycyrrhiza Glabra Root Extract)---[1] 97 💬
35Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)[1] Reynoutria multiflora root (Polygonum Multiflorum Root Extract)---[1] 6 💬
36HP-3000 (ropinirole hydrochloride patch)[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
37HP-3000(ropinirole hydrochloride patch)[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
38Humira 40 mg injekcní roztok v predplnené injekcní stríkacce[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 96 💬
39HYDROCORTISONE ROUSSEL[1] Hydrocortisone (Rodan and Fields Soothe)[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
40IDEC-C2B8, Ro 45-2294----[1] 64 💬
41IgG IL2/RO7049665----[1] 95 💬
42Interferon Alfa-2A
(Roferon A)		[2] Interferon alfa,
Interferon alfa-2a (Roferon A Soln Inj 6 Million)		[2] Interferon alfa-2a (Roferon A),
Interferon alfa 💬 		[2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 56 💬
43LY03003 ( Rotigotine, extended-release microspheres)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
44LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
45LY03003( the name of rotigotine)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
46LY03003(Rotigotine,extended-release microspheres)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
47Magnesium with ropivacaine[2] Magnesium (Rocky Mountain Multiple Vit and Min Mega Tab),
Ropivacaine (Ropivacaine Hydrochloride Injection USP)		[1] Ropivacaine (Ropivacaine) 💬 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 70 💬
48Mesalazine
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[3] 46, 96, 97 💬
49Mesalazine (3,600 mg)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
50Mesalazine (Asacol®)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
51Mesalazine (Mesalamine)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 96 💬
52Mesalazine - TID 1000 mg
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
53Mesalazine - TID 2x 500 mg
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
54Mesalazine 1000 mg gastro-resistant tablets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
55Mesalazine 250Mg
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
56Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
(Rowasa)		[2] Mesalazine (Rowasa),
Nitazoxanide		[2] Mesalamine (Rowasa),
Nitazoxanide 💬 		--[1] 97 💬
57Mesalazine 4G Enema
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
58Mesalazine 500 mg gastro-resistant tablets (Salofa
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
59Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
60Mesalazine EC 500 mg
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 96 💬
61Mesalazine Enema
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
62Mesalazine liquid enema
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
63Mesalazine slow-release granules
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
64Mesalazine Sustained-Release Tablets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 96 💬
65Mesalazine tablet
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
66Mesalazine tablets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 96 💬
67Mesalazine with hydrocortisone sodium succinate
(Rowasa)		[2] Hydrocortisone (Rodan and Fields Soothe),
Mesalazine (Rowasa)		[2] Hydrocortisone ,
Mesalamine (Rowasa) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
68Mesalazine, Tripterygium glycosides
(Rowasa)		[2] Mesalazine (Rowasa),
Tripterygium wilfordii whole		[1] Mesalamine (Rowasa) 💬 --[1] 96 💬
69MINOXIDIL
(Rogaine)		[1] Minoxidil (Rory for Women Hair Regrowth Treatment)[1] Minoxidil (Rogaine) 💬 [2] ABCC8,
KCNJ11 💬 		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[1] 179 💬
70MMX mesalamine/ mesalazine
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
71MMX Mesalamine/Mesalazine
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
72MMX Mesalamine/Mesalazine (High Dose)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
73MMX Mesalamine/Mesalazine (Low Dose)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
74Ocrelizumab (Roche, Switzerland)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
75Oral roflumilast[1] Roflumilast (Roflumilastum)[1] Roflumilast (Roflumilast) 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 299 💬
76Overencapsulated mesalazine tablets
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
77PET with 11C-Flumazenil
(Romazicon)		[1] Flumazenil (Romazicon)[1] Flumazenil (Romazicon) 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13 💬
78Pramipexole or ropinirole[2] Pramipexole,
Ropinirole (Ropinirole Tablets)		[2] Pramipexole ,
Ropinirole (Ropinirole, Ropitor) 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
79PRO145223 (RO5490261)----[1] 97 💬
80PZN 8881655(RochePharma AG)----[1] 85 💬
81R-roscovitine[1] Seliciclib (R-roscovitine)---[1] 75 💬
82RAD001 round tablets----[1] 158 💬
83Ramelteon
(Rozerem)		[1] Ramelteon (Rozerem)[1] Ramelteon (Rozerem) 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[3] 6, 8, 46 💬
84Rapamycin-calcitriol combination
(Rocaltrol)		[2] Calcitriol (Rocaltrol),
Sirolimus		[2] Calcitriol (Rocaltrol),
Sirolimus 💬 		[2] MTOR,
VDR 💬 		[55] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 158 💬
85Recombinant human growth hormone + rosiglitazone[2] Rosiglitazone (Rosiglitazona),
Somatotropin		[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 265 💬
86Riluzole Oral Soluble film (ROSF) 50 mg[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
87RO----[1] 6 💬
88Ro 001-9265----[1] 41 💬
89Ro 001-9265/F02----[1] 41 💬
90RO 001-9265/F02-01----[1] 46 💬
91Ro 001-9265/F03----[1] 41 💬
92Ro 001-9265/F04----[1] 41 💬
93Ro 002-9893/F02----[1] 46 💬
94Ro 106-1443----[1] 49 💬
95Ro 45-2294----[1] 46 💬
96Ro 47-0203----[4] 51, 85, 86, 88 💬
97Ro 47-0203 / ACT-050088----[1] 86 💬
98Ro 48-77533----[1] 46 💬
99Ro 487-533/F01----[1] 271 💬
100Ro 487-5733/F01----[1] 271 💬
101RO 487-7533----[1] 46 💬
102Ro 487-7533/F01----[3] 46, 107, 271 💬
103Ro 487-7533/F10----[2] 46, 107 💬
104Ro 487-7533/F10-02----[1] 46 💬
105Ro 487-7533/F10-04----[4] 41, 46, 51, 107 💬
106Ro 491-7523/F18----[1] 206 💬
107Ro 491-7523/F19----[1] 206 💬
108RO 496-4913----[2] 46, 49 💬
109Ro 496-4913/F03----[2] 13, 46 💬
110Ro 496-4913/F07----[1] 13 💬
111Ro 533-3787/F01- 06----[1] 13 💬
112Ro 533-3787/F01-06----[1] 11 💬
113Ro 549-0261/F04----[1] 97 💬
114Ro 549-0261/F04-02----[1] 96 💬
115Ro 549-0261/F08-02----[1] 96 💬
116RO 551-6922----[1] 46 💬
117Ro 723-4292/F02----[1] 8 💬
118Ro Actemra[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
119Ro-47-0203----[1] 86 💬
120Ro-47-0203/029----[1] 86 💬
121RO-496-4913----[1] 46 💬
122Ro-Actemra[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
123RO001-9265/F04----[1] 46 💬
124RO0029893----[1] 46 💬
125RO0220912----[1] 85 💬
126RO0280296----[1] 85 💬
127RO045-2294----[1] 46 💬
128RO0452294/V01----[2] 43, 44 💬
129RO0452294/V02----[3] 35, 43, 44 💬
130RO0485337----[1] 222 💬
131RO04877533----[1] 46 💬
132RO04877533/F05/F04----[1] 46 💬
133RO0506997----[2] 13, 46 💬
134Ro106-1443----[1] 43 💬
135RO1061443/F02----[1] 35 💬
136RO3300074----[1] 231 💬
137RO4402257----[1] 46 💬
138Ro45-2294----[1] 271 💬
139RO452294/V02----[1] 46 💬
140Ro47-0203----[1] 86 💬
141Ro47-0203 / ACT-050088----[2] 51, 86 💬
142Ro487-7533----[1] 46 💬
143RO487-7533/F01-F05----[1] 46 💬
144RO487-7533/F10-04----[2] 46, 51 💬
145RO4877533----[2] 46, 107 💬
146RO4877533 (TCZ)----[2] 46, 107 💬
147RO4877533/F01----[1] 46 💬
148RO4877533/F04-F05----[1] 46 💬
149RO4917523----[1] 206 💬
150RO4917523 0.5 mg----[1] 206 💬
151RO4917523 1.5 mg----[1] 206 💬
152RO496-4913----[1] 46 💬
153RO4964913----[1] 13 💬
154RO4964913 F07----[1] 13 💬
155RO4964913/F03----[1] 13 💬
156RO4964913/F07----[1] 13 💬
157RO4964913/F07-01----[1] 13 💬
158RO5072759----[1] 222 💬
159RO5333787----[2] 11, 13 💬
160RO545-9072/F03----[1] 53 💬
161RO5459072----[1] 53 💬
162Ro549-0261/F04-02----[1] 96 💬
163RO5490255----[1] 85 💬
164RO5490255/F01-02----[1] 85 💬
165RO5490261 / F02----[1] 97 💬
166RO5490261/F02----[1] 97 💬
167RO5490261/F04-02----[1] 97 💬
168RO5534262 EMICIZUMAB[1] Emicizumab[1] Emicizumab 💬 [2] F10,
F9 💬 		[1] Complement and coagulation cascades 💬[1] 288 💬
169RO6885247----[1] 3 💬
170RO6885247/F02----[1] 3 💬
171RO6885247/F03----[1] 3 💬
172RO7010939----[2] 13, 46 💬
173RO7010939/F13----[1] 49 💬
174RO7021610----[1] 97 💬
175RO7034067----[1] 3 💬
176RO7034067 / F12----[1] 3 💬
177RO7034067 / F13----[1] 3 💬
178RO7034067/F06 + solvente (RO----[1] 3 💬
179RO7034067/F06 with solvent (RO7034067/F08)----[1] 3 💬
180RO7034067/F07 + solvente (RO----[1] 3 💬
181RO7034067/F07 with solvent (RO7034067/F09)----[1] 3 💬
182RO7034067/F12----[1] 3 💬
183RO7034067/F13----[1] 3 💬
184RO7046015----[1] 6 💬
185RO7046015/PRASINEZUMAB[1] Prasinezumab[1] Prasinezumab 💬 [1] SNCA 💬 [3] Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[1] 6 💬
186RO7049665----[2] 95, 97 💬
187RO7049665/IgG-IL2/ IgG-IL2ND2----[1] 95 💬
188RO7090919----[1] 3 💬
189RO7112689----[1] 62 💬
190RO7112689/F01----[1] 62 💬
191RO7112689/F03-01----[2] 62, 109 💬
192RO7112689/F03-10----[2] 62, 109 💬
193RO7121932----[1] 13 💬
194RO7123520----[1] 46 💬
195RO7123520/F03-01----[1] 46 💬
196RO7204239----[2] 3, 113 💬
197RO7204239/F01-01----[1] 3 💬
198RO7234292----[1] 8 💬
199RO7234292 (RG6042)----[1] 8 💬
200RO7239361----[1] 113 💬
201RO7239361 (BMS-986089)----[1] 113 💬
202RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL)----[1] 113 💬
203RO7239361 Injections, 35 mg/Syringe (50 mg/mL)----[1] 113 💬
204RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL)----[1] 113 💬
205RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL)----[1] 113 💬
206RO7246311----[1] 97 💬
207RO7248824----[1] 201 💬
208RO7248824/F02-01----[1] 201 💬
209RO7248824/F03-01 (Diluent for RO7248824/F02-01----[1] 201 💬
210RO7303509----[1] 51 💬
211RO7490677----[1] 85 💬
212RO7490677 160 mg/8 ml----[1] 85 💬
213RO7490677 160 mg/8mL----[1] 85 💬
214RO7490677 160mg/8mL----[1] 85 💬
215RO7490677 320 mg/16 ml (2nd generation)----[1] 85 💬
216RO7490677 320mg/16mL (1st generation)----[1] 85 💬
217RO7490677 320mg/16mL (2nd generation)----[1] 85 💬
218RO7490677/ F01-02----[1] 85 💬
219RO7490677/F01-01----[1] 85 💬
220RO7490677/F01-02----[1] 85 💬
221RO7490677/F01-03----[1] 85 💬
222RoActemra[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[11] 40, 41, 44, 46, 50, 51, 86, 107, 266, 271, 331 💬
223RoActemra (R)[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
224ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 51 💬
225ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
226RoActemra 162 mg[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 51 💬
227RoActemra 162 mg solution for injection in pre-filled syringe[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬
228RoActemra 162 mg solution injectable en seringue préremplie[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
229RoActemra 162 mg soluzione iniettabile in siringa preriempita[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 50 💬
230RoActemra 20 mg/ml concentrado para solución para perfusión[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
231RoActemra 20 mg/ml Concentrate for solution for infusion[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
232RoActemra 20 mg/ml concentrate for solution for infusion.[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
233ROACTEMRA 20 mg/ml, concentrado para solución para perfusión[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[3] 46, 107, 271 💬
234RoActemra 20mg/ml[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 40 💬
235RoActemra(R)[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
236RoActemra/Actemra (tocilizumab)[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 107 💬
237RoActemra®[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 271 💬
238RoActemra® 20mg/ml Konzentrat[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 266 💬
239RoActemra®EV Product Code: PRD82321[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
240RoActerma----[1] 46 💬
241RoActmera----[1] 46 💬
242Rob 803----[1] 46 💬
243Rob 803 (9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxali----[1] 46 💬
244Rob 803 (capsules 12.5 mg)----[1] 46 💬
245Rob 803 (capsules 15 mg)----[1] 46 💬
246Rob 803 (capsules 25 mg)----[1] 46 💬
247Rob 803 (capsules 6.25 mg)----[1] 46 💬
248Rob 803 12.5mg capsule----[1] 46 💬
249Rob 803 15mg capsule----[1] 46 💬
250Rob 803 25mg capsule----[1] 46 💬
251Rob 803 6.25mg capsule----[1] 46 💬
252Rob 803 6.5mg capsule----[1] 46 💬
253Rocuronium[1] Rocuronium (Rocuronium Bromide Injection Sdz)---[2] 70, 296 💬
254Rocuronium Bromide[1] Rocuronium (Rocuronium Bromide Injection Sdz)---[1] 70 💬
255Rodatristat ethyl----[1] 86 💬
256Rodatristat ethyl 300 mg tablet BID----[1] 86 💬
257Rodatristat ethyl 600 mg BID----[1] 86 💬
258Rofecoxib[1] Rofecoxib (Rofécoxib)[1] Rofecoxib (Rofecoxib) 💬 [1] PTGS2 💬 [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
259Roferon-A[1] Interferon alfa-2a (Roferon A Soln Inj 6 Million)[1] Interferon alfa-2a (Roferon A) 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 56 💬
260Roferon-A 3miu[1] Interferon alfa-2a (Roferon A Soln Inj 6 Million)[1] Interferon alfa-2a (Roferon A) 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 56 💬
261Roferon-A, 3miu[1] Interferon alfa-2a (Roferon A Soln Inj 6 Million)[1] Interferon alfa-2a (Roferon A) 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 56 💬
262Roferon-A, 4.5miu[1] Interferon alfa-2a (Roferon A Soln Inj 6 Million)[1] Interferon alfa-2a (Roferon A) 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 56 💬
263Roferon-A, 6miu[1] Interferon alfa-2a (Roferon A Soln Inj 6 Million)[1] Interferon alfa-2a (Roferon A) 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 56 💬
264Roflumilast[1] Roflumilast (Roflumilastum)[1] Roflumilast (Roflumilast) 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[4] 84, 97, 206, 299 💬
265Roflumilast 500 Ug ORAL TABLET [Daliresp][1] Roflumilast (Roflumilastum)[1] Roflumilast (Roflumilast) 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 97 💬
266Roflumilast Oral Tablet[1] Roflumilast (Roflumilastum)[1] Roflumilast (Roflumilast) 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 299 💬
267Rokan (r) Novo 120 mg----[1] 18 💬
268Rolipram[1] Rolipram (Rolipramum)[1] Rolipram (Rolipram) 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[2] 8, 13 💬
269Romiplostim[1] Romiplostim (Romiplostim)[1] Romiplostim (Romiplostim, Romiplostim, Romiplate) 💬 [1] MPL 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[4] 60, 63, 64, 65 💬
270Romiplostim plus dexamethasone[2] Dexamethasone (Ropidex),
Romiplostim (Romiplostim)		[2] Dexamethasone ,
Romiplostim (Romiplostim, Romiplostim, Romiplate) 💬 		[2] MPL,
NR3C1 💬 		[3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
271Romiplostin----[1] 63 💬
272ROMOSOZUMAB[1] Romosozumab (Romosozumab)[1] Romosozumab (Romosozumab, Romosozumab, Romosozumab-aqqg) 💬 [1] SOST 💬 [2] Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬[1] 274 💬
273Rontalizumab[1] Rontalizumab (Rontalizumab)[1] Rontalizumab (Rontalizumab) 💬 [13] IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬 		[25] Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬[1] 49 💬
274ROP----[1] 6 💬
275ROP+L-Dopa[1] Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
276ROPINIROLE[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 74, 309 💬
277Ropinirole (as hydrochloride)[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
278Ropinirole controlled-release (REQUIP CR) for RLS[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
279Ropinirole CR 2mg tablet[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
280Ropinirole CR 8mg tablet[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
281Ropinirole Hydrochloride[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 309 💬
282Ropinirole hydrochloride extended-release tablet[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
283Ropinirole hydrochloride extended-release tablet placebo[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
284Ropinirole hydrochloride prolonged release[2] Manganese citrate,
Ropinirole (Ropinirole Tablets)		[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
285Ropinirole immediate release[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
286Ropinirole Implant[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
287Ropinirole IR[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
288Ropinirole IR Tablets[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
289Ropinirole monotherapy[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
290Ropinirole oral product[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
291Ropinirole PR[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
292Ropinirole PR, 2mg[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
293Ropinirole PR/XR[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
294Ropinirole PR/XR Tablets[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
295Ropinirole Prolonged release[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
296Ropinirole prolonged release/extended release(PR/XR)[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
297Ropinirole XL[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
298Ropinirole XL (formerly CR)[1] Ropinirole (Ropinirole Tablets)[1] Ropinirole (Ropinirole, Ropitor) 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
299Ropinirole/L-dopa[2] Levodopa,
Ropinirole (Ropinirole Tablets)		[2] Levodopa ,
Ropinirole (Ropinirole, Ropitor) 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
300Ropivacaine[1] Ropivacaine (Ropivacaine Hydrochloride Injection USP)[1] Ropivacaine (Ropivacaine) 💬 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[4] 22, 36, 46, 70 💬
301Ropivacaine Hydrochloride Injection[1] Ropivacaine (Ropivacaine Hydrochloride Injection USP)[1] Ropivacaine (Ropivacaine) 💬 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 70 💬
302Ropivacaine plus normal saline[1] Ropivacaine (Ropivacaine Hydrochloride Injection USP)[1] Ropivacaine (Ropivacaine) 💬 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 70 💬
303Roscovitine----[1] 299 💬
304Rosiglitazone[1] Rosiglitazone (Rosiglitazona)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[5] 46, 75, 97, 222, 265 💬
305Rosiglitazone (Avandia)[1] Rosiglitazone (Rosiglitazona)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 222 💬
306Rosiglitazone Extended Release Tablets[1] Rosiglitazone (Rosiglitazona)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 46 💬
307Rosiglitazone maleate[1] Rosiglitazone (Rosiglitazona)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[3] 46, 75, 265 💬
308Rosiglitazone XR[1] Rosiglitazone (Rosiglitazona)[1] Rosiglitazone (Rosiglitazone) 💬 [1] PPARG 💬 [11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 46 💬
309Rosuvastatin[1] Rosuvastatin (Ag-rosuvastatin)[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[11] 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
310Rosuvastatin 10 mg[1] Rosuvastatin (Ag-rosuvastatin)[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 96 💬
311Rosuvastatin 10mg[1] Rosuvastatin (Ag-rosuvastatin)[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 97 💬
312Rosuvastatin 20mg[1] Rosuvastatin (Ag-rosuvastatin)[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 79 💬
313ROSUVASTATIN CALCIUM[2] Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin (Ag-rosuvastatin)		[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[4] 49, 79, 97, 299 💬
314Rosuvastatin calcium 40mg[2] Calcium (Rocky Mountain Multiple Vit and Min Mega Tab),
Rosuvastatin (Ag-rosuvastatin)		[1] Rosuvastatin (Rosuvastatin) 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 56 💬
315Rosuvastatine EG----[1] 97 💬
316ROT-TDS 8 mg/24 h----[1] 6 💬
317Rotigotin----[1] 6 💬
318ROTIGOTINA[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
319ROTIGOTINE[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
320Rotigotine (Reference product PR 2.1.1)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
321Rotigotine (Test product PR 2.3.1)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
322Rotigotine hydrochloride[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
323Rotigotine Nasal Spray[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
324Rotigotine transdermal patch[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
325Rotigotine transdermal patch 2mg/24h(10cm2)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
326Rotigotine transdermal patch 4mg/24h (20cm2)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
327Rotigotine transdermal patch 6mg/24h (30cm2)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
328Rotigotine transdermal patch 8mg/24h (40cm2)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
329Rotigotine TTS (Test)[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
330Rotigotine, extended-release microspheres[1] Rotigotine (Rotigotine)[1] Rotigotine (Rotigotine) 💬 [1] DRD2 💬 [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
331Routine steroid administration group----[1] 85 💬
332Routine transdermal oestrogen patch----[1] 78 💬
333Routine Treatment of CD----[1] 96 💬
334Roxithromycin[1] Roxithromycin (Roxithromycinum)[1] Roxithromycin (Roxithromycin) 💬 --[2] 46, 299 💬
335Royal jelly[1] Royal jelly (Royal jelly)[1] Royal jelly (Royal jelly) 💬 --[1] 49 💬
336ROZANOLIXIZUMAB[1] Rozanolixizumab (Rozanolixizumab)[1] Rozanolixizumab (Rozanolixizumab, Rozanolixizumab) 💬 [1] FCGRT 💬 -[3] 11, 14, 63 💬
337ROZEREM[1] Ramelteon (Rozerem)[1] Ramelteon (Rozerem) 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 6 💬
338Rozibafusp Alfa----[1] 49 💬
339Satralizumab (RO5333787/Enspryng /SA237)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
340Satralizumab (RO5333787/Enspryng/SA237)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
341Satralizumab (RO5333787/SA237)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
342Satrazlizumab (RO5333787/ Enspryng /SA237)[1] Satralizumab[1] Satralizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
343Selective Nerve Root Block----[1] 70 💬
344SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE----[1] 166 💬
345SPD476 (mesalazine)
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
346SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
(Rowasa)		[1] Mesalazine (Rowasa)[1] Mesalamine (Rowasa) 💬 --[1] 97 💬
347Standardized turmeric root extract[1] Turmeric (Turmeric Root Extract)---[1] 299 💬
348Tocilizumab (Actemra or RoActemra)[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
349Tocilizumab [RoActemra/Actemra][1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[4] 46, 51, 107, 331 💬
350Tocilizumab [RoActemra][1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
351Tocilizumab Infusion RoAcemtra (EU)[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 266 💬
352Tocilizumab Roche[1] Tocilizumab (Roactemra)[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
353Tolicizumab Roche----[1] 46 💬
354Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant)----[1] 6 💬
355Tramadol with ropivacaine[2] Ropivacaine (Ropivacaine Hydrochloride Injection USP),
Tramadol		[2] Ropivacaine (Ropivacaine),
Tramadol 💬 		[6] OPRM1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[6] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction 💬[1] 70 💬
356Transdermal flumazenil (Added 4/2020)
(Romazicon)		[1] Flumazenil (Romazicon)[1] Flumazenil (Romazicon) 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 6 💬
357Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere[1] Dulaglutide[1] Dulaglutide 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 13 💬
358Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.[1] Dulaglutide[1] Dulaglutide 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 13 💬
359UTTR1147A/RO7021610 (Active)----[2] 96, 97 💬